These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26826787)

  • 1. TAVR--A new way to treat ventricular storm and ventricular fibrillation.
    Ruf T; Mues C; Tomala J; Ibrahim K; Quick S; Speiser U; Strasser RH
    Int J Cardiol; 2016 Apr; 208():36-9. PubMed ID: 26826787
    [No Abstract]   [Full Text] [Related]  

  • 2. Valve-in-Valve Transcatheter Aortic Valve Replacements: To TEE or not to TEE?
    Khoche S; Pollock J; Golts E
    J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1720-1723. PubMed ID: 28684186
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial.
    Douglas PS; Hahn RT; Pibarot P; Weissman NJ; Stewart WJ; Xu K; Wang Z; Lerakis S; Siegel R; Thompson C; Gopal D; Keane MG; Svensson LG; Tuzcu EM; Smith CR; Leon MB
    J Am Soc Echocardiogr; 2015 Feb; 28(2):210-7.e1-9. PubMed ID: 25455544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TEE-guided transcatheter aortic valve implantation with "zero contrast" - a viable alternative for patients with chronic kidney disease.
    Pershad A; Fraij G; Girotra SV; Fang HK; Gellert G
    J Invasive Cardiol; 2015 Feb; 27(2):E25-6. PubMed ID: 25661767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
    Kapadia SR; Leon MB; Makkar RR; Tuzcu EM; Svensson LG; Kodali S; Webb JG; Mack MJ; Douglas PS; Thourani VH; Babaliaros VC; Herrmann HC; Szeto WY; Pichard AD; Williams MR; Fontana GP; Miller DC; Anderson WN; Akin JJ; Davidson MJ; Smith CR;
    Lancet; 2015 Jun; 385(9986):2485-91. PubMed ID: 25788231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of device landing zone calcification on paravalvular regurgitation after transcatheter aortic valve replacement: a real-time three-dimensional transesophageal echocardiographic study.
    Mihara H; Shibayama K; Berdejo J; Harada K; Itabashi Y; Siegel RJ; Kashif M; Jilaihawi H; Makkar RR; Shiota T
    J Am Soc Echocardiogr; 2015 Apr; 28(4):404-14. PubMed ID: 25560483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary Angiography and Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement.
    Yudi MB; Sharma SK; Tang GHL; Kini A
    J Am Coll Cardiol; 2018 Mar; 71(12):1360-1378. PubMed ID: 29566822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter aortic valve replacement: experience with the transapical approach, alternate access sites, and concomitant cardiac repairs.
    Aguirre J; Waskowski R; Poddar K; Kapadia S; Krishnaswamy A; McCullough R; Mick S; Navia JL; Roselli EE; Tuzcu ME; Sabik JF; Lytle BW; Svensson LG
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1417-22. PubMed ID: 24993618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Fluoroscopy-Echocardiography Fusion Imaging in Transcatheter Aortic Valve Replacement.
    Eskandari M; Dworakowski R; Byrne J; Wendler O; MacCarthy P; Monaghan M
    Echocardiography; 2016 Jul; 33(7):1108-12. PubMed ID: 27095566
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving the accuracy of effective orifice area assessment after transcatheter aortic valve replacement: validation of left ventricular outflow tract diameter and pulsed-wave Doppler location and impact of three-dimensional measurements.
    Khalique OK; Hamid NB; Kodali SK; Nazif TM; Marcoff L; Paradis JM; Williams MR; Vahl TP; George I; Leon MB; Hahn RT
    J Am Soc Echocardiogr; 2015 Nov; 28(11):1283-93. PubMed ID: 26323890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter aortic valve implantation in the young.
    Panoulas VF; Sutaria N; Sen S; Frame A; Ariff B; Gopalan D; Galliford J; Taube D; Malik IS; Mikhail GW
    Int J Cardiol; 2016 Jan; 203():626-8. PubMed ID: 26580345
    [No Abstract]   [Full Text] [Related]  

  • 12. A three-dimensional echocardiographic study on aortic-mitral coupling in transcatheter aortic valve replacement.
    Tsang W; Meineri M; Hahn RT; Veronesi F; Shah AP; Osten M; Nathan S; Russo M; Lang RM; Horlick EM
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):950-6. PubMed ID: 23720379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of transcatheter aortic valve replacement on the mitral valve apparatus and mitral regurgitation: real-time three-dimensional transesophageal echocardiography study.
    Shibayama K; Harada K; Berdejo J; Mihara H; Tanaka J; Gurudevan SV; Siegel R; Jilaihawi H; Makkar RR; Shiota T
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):344-51. PubMed ID: 24474596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transatlantic Editorial on Transcatheter Aortic Valve Replacement.
    Thourani VH; Borger MA; Holmes D; Maniar H; Pinto F; Miller C; Rodés-Cabau J; Mohr FW; Schröfel H; Moat NE; Beyersdorf F; Patterson GA; Weisel R
    Ann Thorac Surg; 2017 Jul; 104(1):1-15. PubMed ID: 28633216
    [No Abstract]   [Full Text] [Related]  

  • 15. Subacute thrombosis of left main coronary artery after transcatheter aortic valve replacement.
    Ichimoto E; De Gregorio J
    Cardiol J; 2017; 24(3):336-337. PubMed ID: 28660998
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography.
    Stachon P; Kaier K; Milde S; Pache G; Sorg S; Siepe M; von zur Mühlen C; Zirlik A; Beyersdorf F; Langer M; Zehender M; Bode C; Reinöhl J
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):731-7. PubMed ID: 25759083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement.
    Maan A; Heist EK; Passeri J; Inglessis I; Baker J; Ptaszek L; Vlahakes G; Ruskin JN; Palacios I; Sundt T; Mansour M
    Am J Cardiol; 2015 Jan; 115(2):220-6. PubMed ID: 25465936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation.
    Panoulas VF; Montorfano M; Contri R; Spagnolo P; Agricola E; Pappalardo F; Latib A; Colombo A
    Int J Cardiol; 2015 Feb; 180():199-202. PubMed ID: 25463364
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
    Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
    Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantation of transcatheter aortic valve prosthesis through the ascending aorta concomitant with coronary artery bypass grafting without cardiopulmonary bypass.
    Leal JC; Avanci LE; Abelaira Filho A; Almeida TF; Braile DM
    Rev Bras Cir Cardiovasc; 2014; 29(4):650-3. PubMed ID: 25714221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.